EVT Limited

EVT

AU000000EVT1

Leisure & Recreation

Market Closed - Australian S.E. Other stock markets 02:10:53 2024-05-16 am EDT			5-day change	1st Jan Change
11.72 ^AUD	+1.30%		-2.17%	-4.17%

Apr. 30	Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	MT
Apr. 24	Germany's Evotec Appoints Permanent CEO	MT

Event Hospitality & Entertainment Limited Announces Cessation of David Christopher SEARGEANT as Director

July 03, 2017 at 12:26 am EDT

Event Hospitality & Entertainment Limited announced that David Christopher SEARGEANT ceased to be as director. Date that director ceased is 30 June 2017.

Latest news about EVT Limited

Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	Apr. 30	MT
Germany's Evotec Appoints Permanent CEO	Apr. 24	MT
Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis	Apr. 18	MT
Evotec Names First Chief People Officer	Apr. 17	MT
Jarden Adjusts EVT’s Price Target to AU$11.31 From AU$12.55, Keeps at Overweight	Feb. 15	MT
Transcript : EVT Limited, H1 2024 Earnings Call, Feb 16, 2024	Feb. 15
EVT's Net Profit Declines 72% in Fiscal H1 on Thredbo Impact	Feb. 15	MT
EVT Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 14	CI
Economic Investment Trust Limited Announces Dividend	Feb. 07	MT
Evotec's US Unit Expands Collaboration vs HIV with Advanced BioScience Laboratories	Feb. 07	MT
Evotec Reiterates Trading Regulations Compliance Amid Former CEO’s Late Stock Trades Disclosure	Jan. 22	MT
Evotec Receives $25 Million Under Neuroscience Collaboration with Bristol Myers Squibb	Jan. 08	MT
Correction: Evotec, Owkin Team Up on AI-powered Research Across Oncology, Immunology, Inflammation	Jan. 04	MT
Evotec, Owken Team Up on AI-powered Research Across Oncology, Immunology, Inflammation	Jan. 04	MT
Evotec CEO to Step Down in 2026; Interim Successor Appointed	Jan. 04	MT
Evotec Secures Grant for Teratogenicity Platform	Dec. 19	MT
Economic Investment Trust Announced Final Results of its Substantial Issuer Bid	Dec. 18	MT
Evotec Partners With German Institution for Expanded Autoimmune Diseases Patients Database; Shares Up	Dec. 14	MT
Evotec, Glycotope Partner on Immune Cell Bispecifics Development Against Tumor	Dec. 11	MT
Evotec Signs Strategic Oncology-focused Partnership With Dewpoint Therapeutics	Nov. 07	MT
EVT Limited Provides Earnings Guidance for the Full Year 2023	23-10-19	CI
Transcript : EVT Limited - Shareholder/Analyst Call	23-10-19
Evotec Grants Three Partners Access to R&D Platform in Support of Biotech Innovation	23-09-27	MT
Evotec, Novo Nordisk Partner for Translational Drug Discovery Accelerator	23-09-26	MT
Transcript : EVT Limited, 2023 Earnings Call, Aug 28, 2023	23-08-27

EVT Limited is an Australia-based company, which is engaged in the entertainment, ventures and travel business. The Company operates through five segments: Entertainment, Entertainment Germany, Hotels and Resorts, Thredbo Alpine Resort and Property and Other Investments. The Entertainment segment includes cinema exhibition operations in Australia and New Zealand, technology equipment supplies and servicing, and the State Theatre. The Entertainment Germany segment includes the cinema exhibition operations in Germany. The Hotels and Resorts segment includes the ownership, operation and management of hotels in Australia and New Zealand. The Thredbo Alpine Resort segment includes all the operations of the resort, including property development activities. The Property and Other Investments segment includes property rental, investment properties and investments designated at FVOCI.

Sector

Leisure & Recreation

Calendar

2024-08-18 - Q4 2024 Earnings Release (Projected)

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for EVT Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

11.57 AUD

Average target price

13.08 AUD

Spread / Average Target

+13.05%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Movie Theaters & Movie Products

	1st Jan change	Capi.
EVT LIMITED	-4.17%	1.25B
WANDA FILM HOLDING CO., LTD.	+4.99%	4.13B
AMC ENTERTAINMENT HOLDINGS, INC.	-10.46%	2.02B
SHANGHAI FILM CO., LTD.	-.--%	1.68B
PVR INOX LIMITED	-20.29%	1.51B
HENGDIAN ENTERTAINMENT CO.,LTD	-12.77%	1.36B
KINEPOLIS GROUP NV	-12.19%	1.14B
PT NUSANTARA SEJAHTERA RAYA TBK	-20.74%	1.11B
SMI HOLDINGS GROUP LIMITED	-.--%	818M
CJ CGV CO., LTD.	+0.17%	524M

Movie Theaters & Movie Products

EVT Limited

Equities

EVT

AU000000EVT1

Leisure & Recreation

Event Hospitality & Entertainment Limited Announces Cessation of David Christopher SEARGEANT as Director

Latest news about EVT Limited

Chart EVT Limited

Company Profile

Income Statement Evolution

Ratings for EVT Limited

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Movie Theaters & Movie Products